Animal Disease Diagnostic Laboratory – Able to Detect UK Variant of COVID-19 Virus

Gloved hands disinfect a sample tube with other sample tubes in a stand in the background
Dr. Geoffrey Lossie, avian diagnostician and clinical assistant professor, is a pathologist involved in receiving samples sent to the ADDL. The primary transport containers are disinfected and the samples are prepared to be taken to the Molecular Diagnostic Section of the facility for testing. (Purdue University photo/John Underwood)

Innovators at Purdue’s Animal Disease Diagnostic Laboratory (ADDL) have used their expertise to make the on-campus testing facility one of the only labs in Indiana actively looking for and able to detect the UK variant of the COVID-19 virus. This ability, combined with the university’s data-driven testing approach, has made it possible for cases to be caught, thereby stopping any potential spread among the campus community.

The current PCR test run at the ADDL detects three viral gene targets – two of which must be positive to call the sample positive for SarsCoV2. Identification of the UK (B117) variant strain begins at the point of the ADDL’s analysis of the sample, where one of the three targets, the “S gene,” is absent while the other two gene targets are observed. This “S drop” pattern is a hallmark pattern in the B117 variants, but not all S drops are actually the variant – many are the original strain. When S drop is noted, the sample is sent to another lab on campus for whole genome sequencing of the virus. Sequencing results are typically available in two days and reveal any mutations or changes in the virus’s RNA, which can indicate a COVID-19 variant. All S drop samples detected at Purdue are sent to the Indiana State Department of Health, which then forwards the samples to the CDC.

More than 55,000 tests have been conducted since January 1. Of just over 1,000 positive tests in the spring semester, five cases of the UK COVID-19 variant have been confirmed in the Purdue campus community. The cases were detected as part of the university’s robust testing and contact tracing protocol and in collaboration with the Tippecanoe County Health Department and the Indiana Department of Health.

Four cases of the UK variant were detected in students during pre-arrival testing for the spring semester — two were roommates, and the other two unrelated. Each was arriving to campus from an international location. As previously announced, all students were required to have a negative test before the beginning of classes, and all students traveling internationally were and are required to quarantine before accessing campus. The four pre-arrival positives for the UK variant were discovered during that quarantine period. Contact tracing found that there was no spread due to the quarantine plan. The fifth case was recently identified in an individual who works in health care off campus. They have undergone isolation and contact tracing as well.

The Protect Purdue Chief Medical Officer, Dr. Esteban Ramirez, has discussed the presence of the variant and quarantine efforts during live-streamed Purdue Provost’s Conversations and during public Tippecanoe County Health Department briefings. “Our unique internal testing ability made us fortunate and able to catch the initial cases before returning to campus,” Dr. Ramirez said. “PPHC has not yet seen any difference in the severity in the small number of variant cases we have detected.”

Campus leaders, in consultation with the Protect Purdue Medical Advisory Team and Tippecanoe County health leaders, are examining closely the latest available evidence on the COVID-19 virus and newly reported strains, which also have been detected elsewhere in Indiana. Per the CDC, these new strains, which appear to spread more easily among individuals, do not appear to lead to more severe illness or increased risk of death at this time.

Importantly, all current strategies for mitigating the spread of the virus remain the most effective tools in protecting ourselves, others, and the Purdue’s community: the de-densification of classrooms and workspaces, physical distancing, avoiding large gatherings, the correct and consistent use of face masks, robust personal hygiene, staying home when sick, promptly isolating the infected and quarantining those in close contact for further evaluation, avoiding unnecessary travel, and proactively pursuing testing when activities or interactions suggest risk of exposure. Diligent adherence to the Protect Purdue Pledge — even in one’s shared residence and when off-campus or off-the-clock — is critically important, now more than ever.

Updates on testing numbers are posted daily on the Protect Purdue dashboard.  More information is available on the Protect Purdue website.

Writer(s): Tim Doty, Purdue News Service | pvmnews@purdue.edu

Recent Stories

“Paws Up” – brought to you by the PVM Wellness Committee

This week, we are proud to recognize Lorraine Fox, who is a business assistant with the Veterinary Medicine Procurement Center.

PVM Interview Days Move College Closer to Admitting the DVM Class of 2030

After a total of three afternoons dedicated to conducting in-person interviews with 226 prospective veterinary students, the Purdue University College of Veterinary Medicine is close to completing the process of admitting 84 members of the incoming first-year DVM class – the Class of 2030.  The students invited for the interview days were selected from a total pool of 1,930 applicants from across the country as well as countries abroad.

Experts to Gather at Purdue for Conference Addressing the Public Health Threat of Antimicrobial Resistance

The ongoing challenges posed by multi-drug resistant infections will be the focus of a multidisciplinary conference taking place in three weeks at Purdue University.  The Fourth Annual Conference on Antimicrobial Resistance is set for February 25–26, 2026 at Purdue’s Stewart Center in West Lafayette. Registration is still open for the event, which will bring together scientists and scholars from human and veterinary medicine, public health, research, and industry to address the determinants, dynamics and deterrence of drug resistance.

PVM’s Upcoming Coppoc One Health Lecture to Focus on Dogs as Sentinels of Environmental Exposure

The Purdue University College of Veterinary Medicine brings a leading One Health scholar to campus each year to address vital health issues from a One Health perspective as part of the Coppoc One Health Lecture series.  This year’s presentation, scheduled for February 26 in Lynn Hall Room 2026, is on the engaging topic, “One Health at Home: Dogs as Sentinels of Environmental Exposure.” The speaker will be Audrey Ruple, DVM, MS, PhD, DACVPM, MRCVS, the Dorothy A. and Richard G. Metcalf Professor of Veterinary Medical Informatics at the Virginia-Maryland College of Veterinary Medicine at Virginia Tech.

“Paws Up” – brought to you by the PVM Wellness Committee

Today we are happy to acknowledge our Student Success Center Team.

One Health: A ‘digital twin’ model for predicting cancer outcomes

The striking similarities between invasive bladder cancer in dogs and humans have fueled research advances for more than three decades. Most of that work has looked at separate aspects of the disease — risk factors, early detection, symptoms, treatment and gene expression. But a new project at Purdue University that combines many types of available data in a “digital twin” model of bladder cancer may prove powerful enough to predict patient outcomes, starting with the probability of metastasis.

Purdue Professor Emeritus Bill Blevins Wins Lifetime Achievement Award at ACVR Annual Meeting

The American College of Veterinary Radiology (ACVR) gave its esteemed Lifetime Achievement Award for 2024 to Purdue Professor Emeritus Bill Blevins, who is well known to countless Purdue Veterinary Medicine alumni for the expertise he taught them about all things Diagnostic Imaging during his long Purdue career.